CSIR brings once-a-week treatment of TB one step closer
Posted on 23. Feb, 2010 by admin in News-Pharmaceutical
Researchers at the Council for Scientific and Industrial Research (CSIR) are one step closer to providing Tuberculosis (TB) sufferers with a once-a-week medicinal regime rather than their current daily doses.
Aspen announces $1m technology transfer
Posted on 02. Feb, 2010 by admin in News-Pharmaceutical
Eli Lilly today announced the US$1 million milestone payment to Aspen, South Africa¹s leading pharmaceutical manufacturer, as part of the joint collaboration on expanding access to medicines to treat multi drug-resistant tuberculosis (MDR-TB). The milestone is part of a Transfer of Technology agreement between Aspen and Lilly, initiated in 2003 under the umbrella of the [...]
Launch of the MRC National Collaborative Research Programme on Cardiovascular and Metabolic Diseases
Posted on 29. Jan, 2010 by admin in News-Pharmaceutical
As we face a growing epidemic around heart disease, diabetes and stroke and other non-communicable diseases in South Africa researchers and scientists have converged in Cape Town to find new health research solutions.
New pharma packaging product from BASF
Posted on 15. Dec, 2009 by admin in News-Pharmaceutical
A new plastic film, for which a patent has been applied, will protect BASF’s pharmaceutical excipient polyvinylpyrrolidone (PVP) in future even better against the penetration of atmospheric oxygen and thus against oxidation. “With this, BASF will be able to offer its customers in the pharmaceutical industry an even higher product quality and, as a result, [...]
Frost & Sullivan Award caps successful month for Cipla Medpro South Africa
Posted on 08. Dec, 2009 by admin in News-Pharmaceutical
News of the award came on the back of Cipla securing new first time government tenders valued at nearly R100 million over two years, the company achieving year to date sales of R1 billion as at the end of October 2009, and the finalization of plans to bring 20 oncology drugs to market in the [...]
Process development provider appointed for CSIR’s anti-rabies antibody
Posted on 03. Nov, 2009 by admin in News-Pharmaceutical
Kentucky BioProcessing has signed an agreement with the Council for Scientific and Industrial Research (CSIR) to develop a commercially efficient process for RabiVirTM, the CSIR’s award-winning anti-rabies antibody developed in a start-up venture with GreenPharmTM.
Aspen CEO re-assures on quality of S26 baby product
Posted on 07. Sep, 2009 by admin in News-Pharmaceutical, Uncategorized
A message from Aspen Group Chief Executive, Stephen Saad, to the mothers of South Africa’s babies:
Quality of S-26 in South Africa Guaranteed
Posted on 30. Aug, 2009 by admin in News-Pharmaceutical, Uncategorized
Aspen Nutritionals, manufacturer of S-26 and other infant milk formulations (IMFs), confirms that all IMFs manufactured and marketed by Aspen Nutritionals are safe for infant consumption.
SPICE4LIFE and Cipla announce partnership
Posted on 25. Aug, 2009 by admin in News-Pharmaceutical
SPICE4LIFE serves as an information portal which gives ‘inspiration, resources and tools for women to thrive in all areas of their lives’. The site amalgamates a large resource of content that offers product, service and value to women across a broad range of topics.
Get serious in natural medicines
Posted on 15. Aug, 2009 by admin in News-Pharmaceutical
Manufacturers and distributors of “Natural medicines” are going to need to work hard to establish themselves as “serious brands” if they want to make inroads into the South African consumers’ pockets. In 2008 we at ManufacturingHub.co.za predicted that one of the areas where we saw growth in the local pharmaceutical market was in and around [...]
